Barclays initiated coverage on LifeStance Health Group with a new price target
$LFST
Medical/Nursing Services
Health Care
Barclays initiated coverage of LifeStance Health Group with a rating of Underweight and set a new price target of $7.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/16/2024 | $10.00 | Neutral → Buy | Goldman |
| 1/3/2024 | $7.00 | Underweight | Barclays |
| 5/15/2023 | $8.00 → $9.00 | Outperform → Market Perform | TD Cowen |
| 1/6/2023 | $8.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/7/2022 | $7.25 | Buy | Jefferies |
| 3/17/2022 | $19.00 → $10.00 | Buy → Neutral | UBS |
| 12/17/2021 | $15.00 → $10.00 | Equal-Weight | Morgan Stanley |
| 11/9/2021 | $24.00 → $12.00 | Overweight → Neutral | JP Morgan |
CHICAGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Zarminali Health, the first outpatient pediatric destination purpose-built to provide modern, seamlessly coordinated primary and specialty care nationwide, today announced $40M in seed financing led by General Catalyst. The company will leverage the latest healthcare technology and an integrated approach to both primary and specialty care that alleviates family burdens and revitalizes patient and clinician experiences. This substantial funding, including a venture debt facility, will fuel the company's go-to-market vision and continue to support the opening of its initial locations in fall 2024 and beyond. Pediatric care today is long overdue f
SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 2787723, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeS
Election stress is contributing to an increase in anxiety and strained relationships, reinforcing the importance of accessible mental healthcare SCOTTSDALE, Ariz., Oct. 8, 2024 /PRNewswire/ -- A LifeStance Health survey released today reveals how widespread election-related anxiety is impacting Americans' mental health, straining their personal relationships and prompting many to limit social media exposure. Nearly four out of five (79%) respondents said the upcoming U.S. presidential election has caused them anxiety this year. Key generational differences were evident, with
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
3 - LifeStance Health Group, Inc. (0001845257) (Issuer)
Goldman upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $10.00
Barclays initiated coverage of LifeStance Health Group with a rating of Underweight and set a new price target of $7.00
TD Cowen downgraded LifeStance Health Group from Outperform to Market Perform and set a new price target of $9.00 from $8.00 previously
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SC 13G/A - LifeStance Health Group, Inc. (0001845257) (Subject)
SCOTTSDALE, Ariz., March 12, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Teresa DeLuca has joined the company's board of directors. Dr. DeLuca is a psychiatrist and accomplished physician executive with over 20 years of leadership experience, having held senior executive leadership roles at Magellan Health, Humana and Walgreens, and brings extensive healthcare operations and clinical management expertise to LifeStance's board of directors. "Dr. DeLuca's background
SCOTTSDALE, Ariz., Jan. 19, 2024 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that Dr. Ujjwal Ramtekkar will join the company as Chief Medical Officer, effective January 22, 2024. He will lead all clinical services, ensuring that LifeStance's psychiatric and psychotherapy clinicians are enabled to deliver high-quality, personalized patient care that meets and exceeds professional standards. "Dr. Ramtekkar is an experienced physician executive with a demonstrated track record of d
SCOTTSDALE, Ariz., Nov. 3, 2022 /PRNewswire/ -- LifeStance Health (NASDAQ:LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that effective November 10, 2022, J. Michael Bruff, currently Chief Financial Officer, will take on a new role as Business Transformation Officer. David Bourdon will join the company and succeed Bruff as Chief Financial Officer. Both executives will report directly to Ken Burdick, Chairman and Chief Executive Officer, LifeStance. During LifeStance's long-range planning process, the company's leadership team ide
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
SCOTTSDALE, Ariz., Oct. 17, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter 2024 earnings release before the market opens on Thursday, November 7, 2024. LifeStance will host a live earnings conference call to discuss third quarter results on November 7, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 2787723, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeS
SCOTTSDALE, Ariz., July 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its second quarter 2024 earnings release before the market opens on Thursday, August 8, 2024. LifeStance will host a live earnings conference call to discuss second quarter results on August 8, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 1488997, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance
SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, will issue its first quarter 2024 earnings release before the market opens on Thursday, May 9, 2024. LifeStance will host a live earnings conference call to discuss first quarter results on May 9, 2024, at 8:30 a.m. Eastern Time. To participate in the call, please dial 1-800-715-9871, domestically, or 1-646-307-1963, internationally, and use conference ID 3005519, or ask to be joined into the LifeStance call. A real-time audio webcast can be accessed via the Events and Presentations section of the LifeStance Investor Re